window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-W287TTH7MD');

Trial news

COLOSSUS translational study update

2021-09-30T10:30:06+00:00September 30th, 2021|

Recruitment to the COLOSSUS translational study will be closing at the end of September 2021. The purpose of the COLOSSUS study is to identify new biomarkers and classifiers for microsatellite stable RAS mutated colorectal cancer. The aim is to develop new diagnostics and therapeutic options for patients bearing this type of cancer after they develop [...]

Introducing Radiomics, a new COLOSSUS sub-stratification tool and VHIO’s Dr Raquel Perez-Lopez

2021-08-23T11:50:36+00:00August 23rd, 2021|

Radiomics: an aspect of COLOSSUS being incorporated into our research plan to bear down on the COLOSSUS-identified subtypes and further sub-stratify MSS RAS mutated colorectal cancer (CRC) to help develop new treatments and drugs. Dr Raquel Perez-Lopez Dr Raquel Perez-Lopez is an experienced academic radiologist trained at the Royal Marsden Hospital and the [...]

Read the COLOSSUS January 2021 newsletter!

2021-01-29T13:22:21+00:00January 29th, 2021|

Our latest newsletter contains a capsule summary of the latest COLOSSUS news. Learn about computational modelling in systems biology with Dr Dirk Fey of University College Dublin. Read the latest update on the COLOSSUS translational trial and our dissemination round-up of presentations, posters, webinars and publications. We feature SME Pintail Limited too. Download it here. [...]

Vall d’Hebron recruits the first COLOSSUS translational trial participant in Spain

2019-11-12T11:31:21+00:00November 6th, 2019|

Pictured (from L to R) Iosune Baraibar, medical oncologist; Mireia Sanchis, Project Manager;  Ariadna Garcia, Research Nurse; Javier Ros, Medical Oncologist; Javier Gonzalo, Project Manager* On November 5, 2019, Dr Rodrigo Dienstmann and the colorectal cancer clinical research team under the leadership of Dr Elena Elez at Vall d'Hebron Institute of Oncology have registered the first person in Spain for [...]

Ireland enrols first person in COLOSSUS translational study

2019-09-23T10:12:57+00:00September 23rd, 2019|

Great news! Dr Brian Bird and his team at Bon Secours Hospital in Cork have registered the first person in Ireland to the COLOSSUS prospective translational trial. Congratulations to the clinical research team! https://twitter.com/DrHealeyBird/status/1174771461313224707?s=20

COLOSSUS – First Patient recruited to Translational Trial

2019-11-01T10:40:07+00:00May 13th, 2019|

The University Hospital Mannheim, Germany, has recruited the first patient to COLOSSUS, an EU-funded Horizon 2020 translational trial which could lead to a ground-breaking new way of treating people with advanced metastatic colorectal cancer. In total, 163 patients will be recruited to take part in the COLOSSUS trial which will validate new and effective stratification [...]

Go to Top